ZNRF3

ZNRF3 Overview

English NameE3 ubiquitin-protein ligase ZNRF3Approved Drugs0
Drugs in Clinical Trials1Target Synonym
Highest Development StagePhase 1 Clinical
English NameE3 ubiquitin-protein ligase ZNRF3
Target Synonym
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 1 Clinical

ZNRF3 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
ZN3-H52H3
Human
HEK293
Human ZNRF3 protein, His Tag (MALS verified)
Total: 1
  • 1

ZNRF3 Background

The transmembrane E3 ubiquitin ligase zinc and ring finger 3 (ZNRF3) is a negative feedback regulator of Wnt signalling. ZNRF3 is associated with the Wnt receptor complex, and inhibits Wnt signalling by promoting the turnover of frizzled and LRP6 and acts as a tumor suppressor in the intestinal stem cell zone by inhibiting the Wnt signaling pathway.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SZN-043SZN-043; SWEETS-1Phase 1 ClinicalSurrozen IncHepatitis, Alcoholic; Liver Cirrhosis
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland